相关实验视频

Updated: Jun 17, 2025

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K

中枢神经系统的长时间反应 在使用向治疗的化学抗原受体T细胞治疗后复发的扩散大B细胞淋巴瘤

Simon Planken1, Sylvia Faict1, Fabienne Trullemans1

  • 1Department of Hematology, Universitair Ziekenhuis Brussel, Jette, BEL.

Cureus
|August 7, 2024
PubMed
概括

化学抗原受体T细胞 (CAR-T) 疗法为扩散性大B细胞淋巴瘤 (DLBCL) 提供了新的希望. 本案例研究探讨了在复发后维持CAR-T细胞的策略,旨在持续治疗疗效.

关键词:
这是一种btk抑制剂.癌症免疫疗法免疫疗法仿制性抗原受体T细胞疗法扩散的大B细胞淋巴瘤治疗顺序的顺序处理.

更多相关视频

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

14.9K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.3K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
67.9K